91 related articles for article (PubMed ID: 19237003)
1. [Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients].
Pascual Pareja JF; Camino A; Larrauri J; López-Diéguez M; Montes ML; González-García J; Peña JM; Díez J; Arribas JR
Med Clin (Barc); 2009 Feb; 132(6):208-13. PubMed ID: 19237003
[TBL] [Abstract][Full Text] [Related]
2. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.
McGovern BH; Ditelberg JS; Taylor LE; Gandhi RT; Christopoulos KA; Chapman S; Schwartzapfel B; Rindler E; Fiorino AM; Zaman MT; Sax PE; Graeme-Cook F; Hibberd PL
Clin Infect Dis; 2006 Aug; 43(3):365-72. PubMed ID: 16804853
[TBL] [Abstract][Full Text] [Related]
4. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
[TBL] [Abstract][Full Text] [Related]
5. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
Gaslightwala I; Bini EJ
J Hepatol; 2006 Jun; 44(6):1026-32. PubMed ID: 16618518
[TBL] [Abstract][Full Text] [Related]
6. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Sánchez-Conde M; Montes Ramírez ML; Bellón Cano JM; Caminoa A; Alvarez Rodríguez F; González Garcia J; Miralles Martín P; Bernardino de la Serna I; Bernardo de Quirós JC; Arribas López JR; Cosín Ochaíta J; Pascual Pareja JF; Alvarez E; Berenguer JB
J Viral Hepat; 2011 Jul; 18(7):e278-83. PubMed ID: 21129129
[TBL] [Abstract][Full Text] [Related]
7. Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection.
Monto A; Dove LM; Bostrom A; Kakar S; Tien PC; Wright TL
Hepatology; 2005 Aug; 42(2):310-6. PubMed ID: 16025515
[TBL] [Abstract][Full Text] [Related]
8. HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/microl at the time of liver biopsy.
Pascual-Pareja JF; Caminoa A; Larrauri C; González-García J; Montes ML; Díez J; Grande M; Arribas JR
AIDS; 2009 May; 23(8):971-5. PubMed ID: 19425223
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.
Machado MV; Oliveira AG; Cortez-Pinto H
Hepatology; 2010 Jul; 52(1):71-8. PubMed ID: 20578130
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.
Neau D; Winnock M; Castéra L; Bail BL; Loko MA; Géraut L; Dupon M; Ragnaud JM; Lacoste D; Lafon ME; Bioulac-Sage P; Dabis F;
J Acquir Immune Defic Syndr; 2007 Jun; 45(2):168-73. PubMed ID: 17527092
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
Woreta TA; Sutcliffe CG; Mehta SH; Brown TT; Higgins Y; Thomas DL; Torbenson MS; Moore RD; Sulkowski MS
Gastroenterology; 2011 Mar; 140(3):809-17. PubMed ID: 21134375
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.
Castéra L; Loko MA; Le Bail B; Coffie P; De Ledinghen V; Trimoulet P; Winnock M; Dabis F; Neau D;
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1489-98. PubMed ID: 17903235
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.
Sulkowski MS; Mehta SH; Torbenson M; Afdhal NH; Mirel L; Moore RD; Thomas DL
AIDS; 2005 Mar; 19(6):585-92. PubMed ID: 15802977
[TBL] [Abstract][Full Text] [Related]
15. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
Rodríguez-Torres M; Govindarajan S; Solá R; Clumeck N; Lissen E; Pessôa M; Buggisch P; Main J; Depamphilis J; Dieterich DT
J Hepatol; 2008 May; 48(5):756-64. PubMed ID: 18314217
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
Guaraldi G; Lonardo A; Ballestri S; Zona S; Stentarelli C; Orlando G; Carli F; Carulli L; Roverato A; Loria P
Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.
Macías J; Berenguer J; Japón MA; Girón-González JA; Rivero A; López-Cortés LF; Moreno A; Márquez M; Iribarren JA; Ortega E; Miralles P; Merchante N; Pineda JA
Hepatology; 2012 Oct; 56(4):1261-70. PubMed ID: 22508322
[TBL] [Abstract][Full Text] [Related]
19. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
Szanto P; Grigorescu M; Dumitru I; Serban A
J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
[TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.
Martinez V; Ta TD; Mokhtari Z; Guiguet M; Miailhes P; Valantin MA; Charlotte F; Bertheau P; Molina JM; Katlama C; Caumes E
BMC Res Notes; 2012 Jul; 5():180. PubMed ID: 22490728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
